Costs of treating primary open-angle glaucoma and ocular hypertension : A retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States
Purpose: The objective of this study was to investigate what treatment strategies prevail in different countries for patients newly diagnosed with primary open-angle glaucoma (POAG) or ocular hypertension (OH) only and initiated on treatment with beta-blockers, and to estimate the total direct cost of treatment for two years. In addition, differences in costs between and within the countries and t
